A kind of clathrate and preparation method thereof
A technology of scutellarin and inclusion compound, which is applied in the directions of active ingredients of hydroxy compounds, pharmaceutical formulations, drug combinations, etc., can solve the problems of instability of scutellarin aqueous injection, difficulty in making aqueous injection, etc., and achieves stable and feasible process. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] The preparation method of the clathrate of the present invention is as follows:
[0040] Weigh 5mg of PA and 90mg of β-CD and put them in a beaker, add 10ml of 50% ethanol to dissolve them, put them on a magnetic heating stirrer, and set the speed at 800r min at 30°C -1 , stirred for 2h, and stood at room temperature. The solution was evaporated under reduced pressure to remove ethanol, filtered through a 0.45 μm microporous membrane to remove unincluded PA, and the filtrate was vacuum-dried at 30° C. to obtain PA-β-CD.
[0041] Three batches of samples were prepared in parallel with the above process, and the content of PA was determined according to the content determination method. The inclusion rates of the three PA-β-CD were: 64.65%, 63.96%, and 63.72%, and the average inclusion rate was 64.11%. The RSD is 0.75%, indicating that the process is stable and feasible.
[0042] The obtained PA-β-CD was dissolved in purified water to obtain a water-injection of luteoli...
Embodiment 2
[0065] The preparation method of the clathrate of the present invention is as follows:
[0066] Weigh 5mg of PA and 135mg of β-CD respectively, put them in a beaker, add 10ml of 80% ethanol to dissolve them, put them on a magnetic heating stirrer, and set the fixed speed at 1200r·min at 20°C -1 , stirred for 3h, and stood at room temperature. The solution was evaporated under reduced pressure to remove ethanol, filtered through a 0.45 μm microporous membrane to remove unincluded PA, and the filtrate was vacuum-dried (30° C.) to obtain PA-β-CD.
[0067] The obtained PA-β-CD was dissolved in purified water to obtain a water-injection of luteolin.
Embodiment 3
[0069] The preparation method of the clathrate of the present invention is as follows:
[0070] Weigh 5mg of PA and 45mg of β-CD respectively, put them in a beaker, add 10ml of 50% ethanol to dissolve them, put them on a magnetic heating stirrer, and set the speed at 800r min at 50°C -1 , stirred for 0.5h, and stood at room temperature. The solution was evaporated under reduced pressure to remove ethanol, filtered through a 0.45 μm microporous membrane to remove unincluded PA, and the filtrate was vacuum-dried (30° C.) to obtain PA-β-CD.
[0071] The obtained PA-β-CD was dissolved in purified water to obtain a water-injection of luteolin.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



